Compare Williams Companies Inc (WMB) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Williams Companies Inc vs Zimmer Biomet Holdings Inc — how do they compare? Williams Companies Inc trades at $72.85 (market cap $88.48B), while Zimmer Biomet Holdings Inc trades at $89.91 (market cap $16.95B). The key difference: Williams Companies Inc is far larger — about 5.2× Zimmer Biomet Holdings Inc's market cap, and Williams Companies Inc pays the higher dividend (2.9%). Which is the better fit depends on your goals — on Pluang, investors hold Williams Companies Inc for 58 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| WMB | ZBH | |
|---|---|---|
Market Cap | $88.48B | $16.95B |
Volume | 9,280,680 | 2,505,240 |
Sector | Energy | Health |
52-Week High | $79.40 | $103.98 |
52-Week Low | $56.51 | $79.58 |
Typical Hold Time | 58 Days | 89 Days |
Enterprise Value | $119.11B | $24.02B |
Dividend Yield | 2.9% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Williams Companies (WMB) trades at $72.67, up 1.69% today, with strong analyst support (79% buy ratings) and a consensus price target of $87.27. The stock shows bullish technical signals with support at $72 and resistance at $73. Fundamentally, WMB delivered $11.95B revenue in 2025 with 25.18% net income margin, though recent quarterly earnings were mixed with one beat and two misses. The company benefits from stable fee-based revenues in the midstream energy sector.
WMB presents a compelling opportunity with dividend growth potential and exposure to rising natural gas demand from data centers. However, investors face risks from energy market volatility and high debt levels. The stock trades at a premium valuation (P/E 28.82) but offers 3% dividend yield with consistent payout increases. Near-term catalysts include Q3 earnings and AI-driven power demand growth.
Zimmer Biomet (ZBH) trades at $89.14, up 0.73% today, with a bearish technical signal but strong recent earnings beats. The stock shows robust fundamentals with a 69.87% gross margin and 2025 revenue of $8.23B, though net income margin has declined from 2023 peaks. Analyst consensus is a Buy with a $103.11 target, indicating potential upside, supported by a steady dividend and institutional accumulation.
The outlook is mixed: valuation metrics like a P/E of 21.57 appear reasonable, and earnings momentum is positive, but technical weakness and rising debt-to-asset ratios pose risks. Investment appeal hinges on execution of commercial transformations and procedure volume recovery, balancing growth prospects against competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
